Correlation Between Franklin Biotechnology and Fidelity Advisor

Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and Fidelity Advisor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and Fidelity Advisor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Biotechnology Discovery and Fidelity Advisor Biotechnology, you can compare the effects of market volatilities on Franklin Biotechnology and Fidelity Advisor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of Fidelity Advisor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and Fidelity Advisor.

Diversification Opportunities for Franklin Biotechnology and Fidelity Advisor

0.82

Correlation Coefficient

Franklin Biotechnology  Fidelity Advisor

Very poor diversification

The 3 months correlation between Franklin and Fidelity is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and Fidelity Advisor Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Advisor Bio and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with Fidelity Advisor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Advisor Bio has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and Fidelity Advisor go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and Fidelity Advisor

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to generate 0.95 times more return on investment than Fidelity Advisor. However, Franklin Biotechnology Discovery is 1.05 times less risky than Fidelity Advisor. It trades about -0.04 of its potential returns per unit of risk. Fidelity Advisor Biotechnology is currently generating about -0.05 per unit of risk. If you would invest  14,688  in Franklin Biotechnology Discovery on September 1, 2024 and sell it today you would lose (510.00) from holding Franklin Biotechnology Discovery or give up 3.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Franklin Biotechnology Discove  vs.  Fidelity Advisor Biotechnology

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fidelity Advisor Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Franklin Biotechnology and Fidelity Advisor

The main advantage of trading using opposite Franklin Biotechnology and Fidelity Advisor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, Fidelity Advisor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Advisor will offset losses from the drop in Fidelity Advisor's long position.

The idea behind Franklin Biotechnology Discovery and Fidelity Advisor Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.